Global Cancer Drugs Market Size By Type (Chemotherapy, Immunotherapy, Hormonal Therapy, Targeted Therapy), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer), By Geography Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Cancer Drugs Market Size By Type (Chemotherapy, Immunotherapy, Hormonal Therapy, Targeted Therapy), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer), By Geography Scope And Forecast
Cancer Drugs Market Size And Forecast
Cancer Drugs Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e.2023 to 2030.
The increasing incidences of Ovarian Cancer are a main key driver for the market. The Global Cancer Drugs Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cancer Drugs Market Definition
Cancer is a large group of diseases that are caused due to abnormal cell growth in any tissue or organ of the body. At the same time, oncology is the branch that studies the diagnosis and treatment of cancer. According to the World Health Organization, cancer is the second largest cause of death globally, accounting for an estimated 9.6 million deaths in 2018. Lung, prostate, stomach, and liver cancer are the most common types of cancer in men, while breast, lung, colorectal, cervical, and thyroid cancer are the most common among women.
Cancer is caused when abnormal cells grow beyond their boundaries and spread to other parts of the body. The major causes of cancer are genetic mutation due to several environmental factors such as exposure to radiation, chemicals, infections, and many other factors like improper diet, obesity, and so on. The mortality rate from cancer has risen with the growing population and causing a huge physical and financial burden on individuals, families, and the healthcare sector of the world. According to the World Bank, out of the 8 million deaths each year worldwide, 5 million deaths occur in low and middle-income countries.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Cancer Drugs Market Overview
Cancer Drugs are used to treat, destroy, control, and prevent cancer cells from spreading to other tissues and organs of the body. They are used in combination with various cancer treatment therapies like chemotherapy, immune therapy, radiation therapy, and so on. They are also useful for treating the symptoms such as sickness, rashes, and pain. The type or class of drug required for the treatment depends on the type of cancer, stage of cancer, and side effects of the drug when used in combination with other drugs. There are several Cancer Drugs approved by the FDA which are extensively used by oncologists. The rising number of cancer patients across the globe is increasing the demand for Cancer Drugs worldwide.
The increasing incidences of Ovarian Cancer are a main key driver for the market. Ovarian cancer is a type of cancer or a condition of uncontrolled growth of cells that form in the ovaries and this proliferation of cells can attack and damage healthy body tissues. There are some of the factors that can increase the risk of Ovarian Cancer include older age, gene changes inherited from the parents, family history of the disease, increased weight or obesity, and others. An unhealthy lifestyle is also a leading cause of increasing Ovarian Cancer and it includes consuming too much junk food, not enough exercise, lack of sleep, and consumption of more alcohol.
There is an increase in the number of patients and growing demand for qualitative treatment is also expected to augment the market. The treatment of Ovarian Cancer involves Surgery, Chemotherapy, Targeted therapy, Hormone therapy, and supportive care. Surgical treatment involves operations to remove one ovary or both ovaries depending upon the stage of its spread, the operation to remove both ovaries and the uterus, and surgery for advanced cancer. Chemotherapy is a drug treatment, which uses chemicals to destroy proliferating cells in the body including cancer cells and the medium for their intake is into a vein or taken by mouth. It can be used after surgical operations to kill the remaining cancerous cells. Hormone therapy deals with the usage of drugs to block the effects of the hormone estrogen on cancer cells.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Cancer Drugs Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the global Cancer Drugs Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Global Cancer Drugs Market Segmentation Analysis
The Global Cancer Drugs Market is Segmented on the basis of Type, Indication, And Geography.
Cancer Drugs Market, By Type
Chemotherapy
Immunotherapy
Hormonal Therapy
Targeted Therapy
Others
Based on Type, the market is segmented into Chemotherapy, Immunotherapy, Hormonal Therapy, Targeted Therapy, and Others. Chemotherapy drugs are extensively used in combination with drugs during chemotherapy. Chemotherapy is a common cancer therapy across the globe that is fueling the growth of drugs in chemotherapy treatment.
Cancer Drugs Market, By Indication
Breast Cancer
Lung Cancer
Prostate Cancer
Liver Cancer
Others
Based on Indication, the market is segmented Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer, and Others. Breast cancer is one most common types of cancer in women, and lung and prostate cancer are the most common types of common cancer caused in men. The rising number of cases of these cancers is fueling the growth of Cancer Drugs.
Cancer Drugs Market, By Geography
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
On the basis of Geography, the Global Cancer Drugs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North American region has dominated the Global Oncology/Cancer Drugs Market due to growing research in drugs development, several government initiatives, and the growth of the pharmaceutical industry in the region. Asia Pacific region is expected to witness significant growth due to the rising population and increasing number of domestic manufacturers.
Key Players
The “Global Cancer Drugs Market” study report will provide valuable insight with an emphasis on the global market including some of the major players Pfizer, Johnson & Johnson, Novartis, Bristol-Myers Squibb Company, AstraZeneca PLC, Hoffmann-La Roche Ltd., Merck & Co., AbbVie Inc., Astellas Pharma Inc., and Amgen Inc. Our market analysis also entails a section solely among others. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2019-2030
BASE YEAR
2022
FORECAST PERIOD
2023-2030
HISTORICAL PERIOD
2019-2020
KEY COMPANIES PROFILED
Pfizer, Johnson & Johnson, Novartis, Bristol-Myers Squibb Company, AstraZeneca PLC, Hoffmann-La Roche Ltd., Merck & Co., AbbVie Inc., Astellas Pharma Inc., and Amgen Inc.
SEGMENTS COVERED
By Type
By Indication
By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Cancer Drugs Market Size By Type (Chemotherapy, Immunotherapy, Hormonal Therapy, Targeted Therapy), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer), By Geography Scope And Forecast